{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T01:05:43Z","timestamp":1781571943830,"version":"3.54.5"},"reference-count":154,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.clintera.2004.12.007","type":"journal-article","created":{"date-parts":[[2005,3,11]],"date-time":"2005-03-11T12:26:37Z","timestamp":1110543997000},"page":"2102-2120","source":"Crossref","is-referenced-by-count":13,"title":["Gold standard medical therapy for glaucoma: Defining the criteria identifying measures for an evidence-based analysis"],"prefix":"10.1016","volume":"26","author":[{"given":"Stephen A.","family":"Obstbaum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George A.","family":"Cioffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guenther K.","family":"Krieglstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Brian","family":"Fennerty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Alm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Araie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto G.","family":"Carassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik L.","family":"Greve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger A.","family":"Hitchings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L.","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Kitazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prin Rojana","family":"Pongpun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Remo","family":"Susanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin B.","family":"Wax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thom J.","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clintera.2004.12.007_bib1","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1001\/jama.276.18.1473","article-title":"Persons with chronic conditions. Their prevalence and costs","volume":"276","author":"Hoffman","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.clintera.2004.12.007_bib2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1377\/hlthaff.20.6.233","article-title":"Comparing the national economic burden of five chronic conditions","volume":"20","author":"Druss","year":"2001","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.clintera.2004.12.007_bib3","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1136\/bmj.323.7319.947","article-title":"The challenge of chronic conditions: WHO responds","volume":"323","author":"Epping-Jordan","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.clintera.2004.12.007_bib4","series-title":"Crossing the Quality Chasm: A New Health System for the 21st Century","author":"Institute of Medicine","year":"2001"},{"key":"10.1016\/j.clintera.2004.12.007_bib5","series-title":"Leadership by Example: Coordinating Government Roles in Improving Health Care Quality","author":"Institute of Medicine","year":"2002"},{"key":"10.1016\/j.clintera.2004.12.007_bib6","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1001\/jama.289.4.434","article-title":"External incentives, information technology, and organized processes to improve health care quality for patients with chronic diseases","volume":"289","author":"Casalino","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.clintera.2004.12.007_bib7","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1377\/hlthaff.20.6.44","article-title":"No Toyotas in health care: Why medical care has not evolved to meet patients' needs","volume":"20","author":"Coye","year":"2001","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.clintera.2004.12.007_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1377\/hlthaff.7.1.19","article-title":"The quality of medical evidence: Implications for quality of care","volume":"7","author":"Eddy","year":"1988","journal-title":"Health Aff (Millwood)"},{"issue":"Suppl 1","key":"10.1016\/j.clintera.2004.12.007_bib9","first-page":"557","article-title":"Treatment adherence in chronic disease","volume":"54","author":"Dunbar-Jacob","year":"2001","journal-title":"J Clin Epidemiol."},{"key":"10.1016\/j.clintera.2004.12.007_bib10","first-page":"13","article-title":"Preferred Practice Pattern: Primary Open-Angle Glaucoma","year":"2000"},{"key":"10.1016\/j.clintera.2004.12.007_bib11","series-title":"Terminology and Guidelines for Glaucoma","author":"European Glaucoma Society","year":"2003"},{"key":"10.1016\/j.clintera.2004.12.007_bib12","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1001\/archopht.122.4.532","article-title":"Prevalence of open-angle glaucoma among adults in the United States","volume":"122","author":"Friedman","year":"2004","journal-title":"Arch Ophthalmol."},{"key":"10.1016\/j.clintera.2004.12.007_bib13","series-title":"World Health Report 1997: Executive Summary: Conquering suffering, enriching humanity","author":"World Health Organization (WHO)","year":"2004"},{"key":"10.1016\/j.clintera.2004.12.007_bib14","first-page":"323","article-title":"The global impact of glaucoma","volume":"72","author":"Thylefors","year":"1994","journal-title":"Bull World Health Organ."},{"key":"10.1016\/j.clintera.2004.12.007_bib15","first-page":"152","author":"World Health Organization (WHO)","year":"2001"},{"key":"10.1016\/j.clintera.2004.12.007_bib16","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1001\/archopht.1991.01080080050026","article-title":"Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey","volume":"109","author":"Sommer","year":"1991","journal-title":"Arch Ophthalmol."},{"key":"10.1016\/j.clintera.2004.12.007_bib17","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/archopht.117.4.450","article-title":"Severity and stability of glaucoma: Patient perception compared with objective measurement","volume":"117","author":"Viswanathan","year":"1999","journal-title":"Arch Ophthalmol."},{"key":"10.1016\/j.clintera.2004.12.007_bib18","first-page":"1059","article-title":"Correlation of the binocular visual field with patient assessment of vision","volume":"43","author":"Jampel","year":"2002","journal-title":"Invest Ophthalmol Vis. Sci."},{"key":"10.1016\/j.clintera.2004.12.007_bib19","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1136\/bjo.85.10.1167","article-title":"Study of retinal nerve fibre layer thickness in eyes with high tension glaucoma and hemifield defect","volume":"85","author":"Kook","year":"2001","journal-title":"Br J Ophthalmol."},{"key":"10.1016\/j.clintera.2004.12.007_bib20","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0021-5155(02)00663-9","article-title":"Study of retinal nerve fiber layer thickness within normal hemivisual field in primary open-angle glaucoma and normal-tension glaucoma","volume":"47","author":"Matsumoto","year":"2003","journal-title":"Jpn J Ophthalmol."},{"key":"10.1016\/j.clintera.2004.12.007_bib21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1001\/archopht.1991.01080010079037","article-title":"Clinically detectable nerve fiber atrophy precedes the onset of glaucomatous field loss","volume":"109","author":"Sommer","year":"1991","journal-title":"Arch Ophthalmol."},{"key":"10.1016\/j.clintera.2004.12.007_bib22","series-title":"Presented at the 1st US Congress House Committee on Appropriations for 1993","first-page":"1317","article-title":"Testimony before Department of Labor, Health and Human Services, and Related Agencies","author":"Lichter","year":"1992"},{"key":"10.1016\/j.clintera.2004.12.007_bib23","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/S0161-6420(94)31118-3","article-title":"Agreement among optometrists, ophthalmologists, and residents in evaluating the optic disc for glaucoma","volume":"101","author":"Abrams","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clintera.2004.12.007_bib24","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/S0161-6420(99)00733-2","article-title":"Optic nerve head and retinal nerve fiber layer analysis","volume":"106","author":"American Academy of Ophthalmology","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clintera.2004.12.007_bib25","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/S0161-6420(01)00768-0","article-title":"Using optical imaging summary data to detect glaucoma","volume":"108","author":"Sanchez-Galeana","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clintera.2004.12.007_bib26","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1001\/archopht.119.7.985","article-title":"Discriminating between normal and glaucomatous eyes using the Heidelberg Retina Tomograph, GDx Nerve Fiber Analyzer, and Optical Coherence Tomograph","volume":"119","author":"Zangwill","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clintera.2004.12.007_bib27","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0161-6420(94)31133-X","article-title":"Errors in the diagnosis of visual field progression in normal-tension glaucoma","volume":"101","author":"Schulzer","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clintera.2004.12.007_bib28","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0161-6420(02)01015-1","article-title":"Short wavelength automated perimetry, frequency doubling technology perimetry, and pattern electroretinography for prediction of progressive glaucomatous standard visual field defects","volume":"109","author":"Bayer","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clintera.2004.12.007_bib29","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1016\/S0161-6420(02)01726-8","article-title":"Automated perimetry: A report by the American Academy of Ophthalmology","volume":"109","author":"Delgado","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clintera.2004.12.007_bib30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0002-9394(02)01818-4","article-title":"Detection of glaucomatous visual field defect by nonconventional perimetry","volume":"135","author":"Iester","year":"2003","journal-title":"Am J Ophthalmol."},{"key":"10.1016\/j.clintera.2004.12.007_bib31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0002-9394(02)01577-5","article-title":"Structure and function evaluation (SAFE): I. Criteria for glaucomatous visual field loss using standard automated perimetry (SAP) and short wavelength automated perimetry (SWAP)","volume":"134","author":"Johnson","year":"2002","journal-title":"Am J Ophthalmol."},{"key":"10.1016\/j.clintera.2004.12.007_bib32","first-page":"764","article-title":"The influence of age-related cataract on blue-on-yellow perimetry","volume":"36","author":"Moss","year":"1995","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"10.1016\/j.clintera.2004.12.007_bib33","first-page":"1993","article-title":"Detecting early glaucoma by assessment of retinal nerve fiber layer thickness and visual function","volume":"42","author":"Bowd","year":"2001","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"10.1016\/j.clintera.2004.12.007_bib34","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0002-9394(98)00046-4","article-title":"Identification of glaucoma-related visual field abnormality with the screening protocol of frequency doubling technology","volume":"125","author":"Quigley","year":"1998","journal-title":"Am J Ophthalmol."},{"key":"10.1016\/j.clintera.2004.12.007_bib35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0002-9394(14)76896-5","article-title":"Correlation between intraocular pressure control and progressive glaucomatous damage in primary open-angle glaucoma","volume":"111","author":"Mao","year":"1991","journal-title":"Am J Ophthalmol."},{"key":"10.1016\/j.clintera.2004.12.007_bib36","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/BF02539409","article-title":"Relationship between optic disc cupping change and intraocular pressure control in adult glaucoma patients","volume":"234","author":"Rath","year":"1996","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"10.1016\/j.clintera.2004.12.007_bib37","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0161-6420(03)00101-5","article-title":"Correlation between intraocular pressure level and optic disc changes in high-tension glaucoma suspects","volume":"110","author":"Tanito","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clintera.2004.12.007_bib38","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0161-6420(01)00873-9","article-title":"Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery","volume":"108","author":"Lichter","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clintera.2004.12.007_bib39","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","article-title":"The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration","volume":"130","year":"2000","journal-title":"Am J Ophthalmol."},{"key":"10.1016\/j.clintera.2004.12.007_bib40","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archopht.120.6.701","article-title":"The Ocular Hypertension Treatment Study: A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma","volume":"120","author":"Kass","year":"2002","journal-title":"Arch Ophthalmol."},{"key":"10.1016\/j.clintera.2004.12.007_bib41","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/archopht.120.6.714","article-title":"The Ocular Hypertension Treatment Study: Baseline factors that predict the onset of primary open-angle glaucoma","volume":"120","author":"Gordon","year":"2002","journal-title":"Arch Ophthalmol."},{"key":"10.1016\/j.clintera.2004.12.007_bib42","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0002-9394(98)00223-2","article-title":"Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures","volume":"126","year":"1998","journal-title":"Am J Ophthalmol."},{"key":"10.1016\/j.clintera.2004.12.007_bib43","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","article-title":"Reduction of intraocular pressure and glaucoma progression: Results from the Early Manifest Glaucoma Trial","volume":"120","author":"Heijl","year":"2002","journal-title":"Arch Ophthalmol."},{"key":"10.1016\/j.clintera.2004.12.007_bib44","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archopht.121.1.48","article-title":"Factors for glaucoma progression and the effect of treatment: The early manifest glaucoma trial","volume":"121","author":"Leske","year":"2003","journal-title":"Arch Ophthalmol."},{"key":"10.1016\/j.clintera.2004.12.007_bib45","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/00055735-199704000-00013","article-title":"Criteria for success of surgical treatment of glaucoma","volume":"8","author":"Caprioli","year":"1997","journal-title":"Curr Opin Ophthalmol."},{"key":"10.1016\/j.clintera.2004.12.007_bib46","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1017\/S0266462300009594","article-title":"Beware of surrogate outcome measures","volume":"12","author":"Gotzsche","year":"1996","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.clintera.2004.12.007_bib47","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1001\/jama.283.21.2829","article-title":"Users' Guides to the Medical Literature: XX. Integrating research evidence with the care of the individual patient","volume":"283","author":"McAlister","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.clintera.2004.12.007_bib48","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1001\/jama.284.10.1290","article-title":"Users' Guides to the Medical Literature: XXV. Evidence-based medicine: Principles for applying the Users' Guides to patient care","volume":"284","author":"Guyatt","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.clintera.2004.12.007_bib49","first-page":"21","author":"Eddy","year":"1992"},{"key":"10.1016\/j.clintera.2004.12.007_bib50","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0161-6420(96)30594-0","article-title":"Clinical trials: The gold standard for evaluation of therapy","volume":"103","author":"Meinert","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clintera.2004.12.007_bib51","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1001\/archopht.1993.01090010100034","article-title":"Randomized clinical trials on medical treatment of glaucoma. Are they appropriate to guide clinical practice?","volume":"111","author":"Rossetti","year":"1993","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clintera.2004.12.007_bib52","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1136\/bmj.310.6987.1085","article-title":"Evidence based medicine","volume":"310","author":"Davidoff","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.clintera.2004.12.007_bib53","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/jama.263.9.1265","article-title":"Practice policies: Where do they come from?","volume":"263","author":"Eddy","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.clintera.2004.12.007_bib54","author":"European Glaucoma Society","year":"1998"},{"key":"10.1016\/j.clintera.2004.12.007_bib55","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1053\/sder.2001.25138","article-title":"Botulinum toxin type A: History and current cosmetic use in the upper face","volume":"20","author":"Carruthers","year":"2001","journal-title":"Semin Cutan Med Surg."},{"key":"10.1016\/j.clintera.2004.12.007_bib56","first-page":"647","article-title":"Update on the management of advanced breast cancer","volume":"13","author":"Fornier","year":"1999","journal-title":"Oncology (Huntingt)"},{"key":"10.1016\/j.clintera.2004.12.007_bib57","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3949\/ccjm.67.8.567","article-title":"Update on antiviral therapy for genital herpes infection","volume":"67","author":"Geers","year":"2000","journal-title":"Cleve Clin J Med"},{"issue":"Suppl 3","key":"10.1016\/j.clintera.2004.12.007_bib58","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1017\/S0317167100000159","article-title":"The scientific basis of medication choice in symptomatic migraine treatment","volume":"26","author":"Goadsby","year":"1999","journal-title":"Can J Neurol Sci."},{"issue":"Suppl 4","key":"10.1016\/j.clintera.2004.12.007_bib59","first-page":"S2","article-title":"Levodopa in the treatment of Parkinson's disease","volume":"55","author":"Koller","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.clintera.2004.12.007_bib60","first-page":"114","article-title":"Low dose methotrexate therapy in chronic polyarthritis\u2014an update [in German]","volume":"23","author":"Leeb","year":"1996","journal-title":"Acta Med Austriaca"},{"key":"10.1016\/j.clintera.2004.12.007_bib61","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2165\/00003495-200161030-00008","article-title":"Drug treatment of scleroderma","volume":"61","author":"Leighton","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.clintera.2004.12.007_bib62","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.2165\/00003495-200060060-00007","article-title":"Current recommendations for the treatment of genital herpes","volume":"60","author":"Leung","year":"2000","journal-title":"Drugs"},{"issue":"Suppl 1","key":"10.1016\/j.clintera.2004.12.007_bib63","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00003495-200161001-00002","article-title":"Current management of fungal infections","volume":"61","author":"Meis","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.clintera.2004.12.007_bib64","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s003920170129","article-title":"Optimal thrombolysis [in German]","volume":"90","author":"Nordt","year":"2001","journal-title":"Z Kardiol"},{"key":"10.1016\/j.clintera.2004.12.007_bib65","first-page":"175","article-title":"Proton pump inhibitory therapy: Then and now","volume":"69","author":"Schepp","year":"1996","journal-title":"Yale J Biol Med."},{"key":"10.1016\/j.clintera.2004.12.007_bib66","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1055\/s-2007-996108","article-title":"Aspirin and platelets: The antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis","volume":"23","author":"Schr r","year":"1997","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.clintera.2004.12.007_bib67","first-page":"128","article-title":"Current and emerging treatments in Parkinson's disease","volume":"30","author":"Tan","year":"2001","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.clintera.2004.12.007_bib68","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1034\/j.1399-3062.1999.010406.x","article-title":"Amphotericin B and its new formulations: Pharmacologic characteristics, clinical efficacy, and tolerability","volume":"1","author":"Tiphine","year":"1999","journal-title":"Transpl Infect Dis."},{"key":"10.1016\/j.clintera.2004.12.007_bib69","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3109\/07853890008998836","article-title":"Antiplatelet medications and their indications in preventing and treating coronary thrombosis","volume":"32","author":"Van De Graaff","year":"2000","journal-title":"Ann Med."},{"key":"10.1016\/j.clintera.2004.12.007_bib70","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1517\/14656566.2.8.1211","article-title":"Genitourinary fungal infections: A therapeutic conundrum","volume":"2","author":"Wise","year":"2001","journal-title":"Expert Opin Pharmacother."},{"key":"10.1016\/j.clintera.2004.12.007_bib71","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1111\/j.1572-0241.1999.1123_a.x","article-title":"Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease","volume":"94","author":"DeVault","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clintera.2004.12.007_bib72","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/BF02071537","article-title":"Maintenance therapy: Is there still a place for antireflux surgery?","volume":"16","author":"Armstrong","year":"1992","journal-title":"World J Surg."},{"key":"10.1016\/j.clintera.2004.12.007_bib73","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/archinte.154.7.721","article-title":"Helicobacter pylori","volume":"154","author":"Fennerty","year":"1994","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.clintera.2004.12.007_bib74","first-page":"1997","article-title":"Omeprazole as a diagnostic tool in gastroesophageal reflux disease","volume":"92","author":"Schenk","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clintera.2004.12.007_bib75","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-2036.1993.tb00101.x","article-title":"Rolling review: Gastro-oesophageal reflux disease","volume":"7","author":"Sontag","year":"1993","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.clintera.2004.12.007_bib76","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/S0016-5085(97)70025-8","article-title":"Prevalence and clinical spectrum of gastroesophageal reflux: A population-based study in Olmsted County, Minnesota","volume":"112","author":"Locke","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clintera.2004.12.007_bib77","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3109\/00365529309098350","article-title":"Methodological aspects of evaluation of quality of life in upper gastrointestinal diseases","volume":"199","author":"Dimenes","year":"1993","journal-title":"Scand J Gastroenterol Suppl."},{"key":"10.1016\/j.clintera.2004.12.007_bib78","first-page":"1347","article-title":"Timolol: Effect on intraocular pressure in chronic open-angle glaucoma","volume":"10","author":"Obstbaum","year":"1978","journal-title":"Ann Ophthalmol."},{"key":"10.1016\/j.clintera.2004.12.007_bib79","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/archopht.1978.03910050527005","article-title":"Timolol. A new drug for management of chronic simple glaucoma","volume":"96","author":"Radius","year":"1978","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clintera.2004.12.007_bib80","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archopht.1977.04450040067008","article-title":"Timolol. A beta-adrenergic blocking agent for the treatment of glaucoma","volume":"95","author":"Zimmerman","year":"1977","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clintera.2004.12.007_bib81","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0039-6257(87)90116-0","article-title":"Ophthalmic beta-blockers since timolol","volume":"31","author":"Novack","year":"1987","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.clintera.2004.12.007_bib82","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1056\/NEJM199810293391808","article-title":"Medical management of glaucoma","volume":"339","author":"Alward","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clintera.2004.12.007_bib83","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2165\/00003495-200059030-00003","article-title":"Pharmacological therapy for glaucoma: A review","volume":"59","author":"Hoyng","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.clintera.2004.12.007_bib84","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1001\/archopht.1979.01020010312004","article-title":"Timolol maleate: Efficacy and safety","volume":"97","author":"Zimmerman","year":"1979","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clintera.2004.12.007_bib85","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0002-9394(99)00160-9","article-title":"Beta-blocker eyedrops and nocturnal arterial hypotension","volume":"128","author":"Hayreh","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clintera.2004.12.007_bib86","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/archopht.1990.01070110076028","article-title":"Topical timolol decreases plasma high-density lipoprotein cholesterol level","volume":"108","author":"Coleman","year":"1990","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clintera.2004.12.007_bib87","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/S0140-6736(95)90116-7","article-title":"Avoiding unsuspected respiratory side-effects of topical timolol with cardioselective or sympathomimetic agents","volume":"345","author":"Diggory","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.clintera.2004.12.007_bib88","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/00004714-198708000-00012","article-title":"Psychiatric side effects from topical ocular timolol, a beta-adrenergic blocker","volume":"7","author":"Shore","year":"1987","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.clintera.2004.12.007_bib89","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0161-6420(80)35215-9","article-title":"Adverse reactions from timolol administration","volume":"87","author":"Van Buskirk","year":"1980","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clintera.2004.12.007_bib90","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1755-3768.1989.tb04110.x","article-title":"Long-term evaluation of timolol","volume":"67","author":"Uusitalo","year":"1989","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"10.1016\/j.clintera.2004.12.007_bib91","first-page":"2566","article-title":"Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension","volume":"41","author":"Orzalesi","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clintera.2004.12.007_bib92","first-page":"89","article-title":"Incidence of open-angle glaucoma: The Barbados Eye Studies","volume":"119","author":"Leske","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clintera.2004.12.007_bib93","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/archopht.1995.01100070092031","article-title":"Risk factors for open-angle glaucoma. The Barbados Eye Study","volume":"113","author":"Leske","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clintera.2004.12.007_bib94","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0002-9394(14)72062-8","article-title":"Rate of progression in open-angle glaucoma estimated from cross-sectional prevalence of visual field damage","volume":"122","author":"Quigley","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clintera.2004.12.007_bib95","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s004170050262","article-title":"Risk factors for the progression of treated primary open-angle glaucoma: A multivariate life-table analysis","volume":"237","author":"Suzuki","year":"1999","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.clintera.2004.12.007_bib96","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0002-9394(98)00272-4","article-title":"The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma","volume":"126","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clintera.2004.12.007_bib97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000310397","article-title":"Intraocular pressure-dependent progression of visual field loss in advanced primary open-angle glaucoma: A 15-year follow-up","volume":"207","author":"Shirakashi","year":"1993","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.clintera.2004.12.007_bib98","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0002-9394(00)00487-6","article-title":"Factors associated with long-term progression or stability in primary open-angle glaucoma","volume":"130","author":"Stewart","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clintera.2004.12.007_bib99","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s004170000189","article-title":"Long-term effects of timolol therapy in ocular hypertension: A double-masked, randomised trial","volume":"238","author":"Heijl","year":"2000","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.clintera.2004.12.007_bib100","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00061198-200004000-00002","article-title":"Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma","volume":"9","author":"Asrani","year":"2000","journal-title":"J Glaucoma"},{"key":"10.1016\/j.clintera.2004.12.007_bib101","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0161-6420(99)00523-0","article-title":"Impact of intraocular pressure regulation on visual fields in open-angle glaucoma","volume":"106","author":"Bergea","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clintera.2004.12.007_bib102","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0161-6420(91)32340-6","article-title":"Association between intraocular pressure peaks and progression of visual field loss","volume":"98","author":"Zeimer","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clintera.2004.12.007_bib103","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/S0149-2918(01)80150-8","article-title":"A comparison of the efficacy and tolerability of brimonidine and latanoprost in adults with open-angle glaucoma or ocular hypertension: A three-month, multicenter, randomized, double-masked, parallel-group trial","volume":"23","author":"DuBiner","year":"2001","journal-title":"Clin Ther"},{"key":"10.1016\/j.clintera.2004.12.007_bib104","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0002-9394(01)01177-1","article-title":"Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension","volume":"132","author":"Netland","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clintera.2004.12.007_bib105","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0002-9394(03)00098-9","article-title":"A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: A 12-week, randomized, masked-evaluator multicenter study","volume":"135","author":"Parrish","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clintera.2004.12.007_bib106","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0161-6420(01)00936-8","article-title":"Three-month comparison of brimonidine and latanoprost as adjunctive therapy in glaucoma and ocular hypertension patients uncontrolled on beta-blockers: Tolerance and peak intraocular pressure lowering","volume":"109","author":"Simmons","year":"2002","journal-title":"Ophthalmology"},{"issue":"Suppl 1","key":"10.1016\/j.clintera.2004.12.007_bib107","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S0039-6257(99)00050-8","article-title":"Vascular aspects in the pathophysiology of glaucomatous optic neuropathy","volume":"43","author":"Chung","year":"1999","journal-title":"Surv Ophthalmol"},{"issue":"Suppl 2","key":"10.1016\/j.clintera.2004.12.007_bib108","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1177\/112067210101102S04","article-title":"Brmonidine's neuroprotective effects against transient ischaemia-induced retinal ganglion cell death","volume":"11","author":"Vidal-Sanz","year":"2001","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.clintera.2004.12.007_bib109","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1001\/archopht.117.11.1540","article-title":"Is neuroprotection a viable therapy for glaucoma?","volume":"117","author":"Weinreb","year":"1999","journal-title":"Arch Ophthalmol"},{"issue":"Suppl 1","key":"10.1016\/j.clintera.2004.12.007_bib110","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1097\/00061198-200110001-00022","article-title":"Measurement of ocular blood flow","volume":"10","author":"Cioffi","year":"2001","journal-title":"J Glaucoma"},{"key":"10.1016\/j.clintera.2004.12.007_bib111","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1034\/j.1600-0420.2002.800111.x","article-title":"The short-term effect of latanoprost on intraocular pressure and pulsatile ocular blood flow","volume":"80","author":"Georgopoulos","year":"2002","journal-title":"Acta Ophthalmol Scand"},{"issue":"Suppl 1","key":"10.1016\/j.clintera.2004.12.007_bib112","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1097\/00061198-200110001-00028","article-title":"Strategies for neuroprotection","volume":"10","author":"Girkin","year":"2001","journal-title":"J Glaucoma"},{"key":"10.1016\/j.clintera.2004.12.007_bib113","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1054\/jocn.2001.1027","article-title":"Neuroprotection and neurodegenerative disease","volume":"9","author":"Vajda","year":"2002","journal-title":"J Clin Neuroscience"},{"issue":"Suppl 3","key":"10.1016\/j.clintera.2004.12.007_bib114","doi-asserted-by":"crossref","first-page":"S241","DOI":"10.1016\/S0039-6257(01)00209-0","article-title":"Neuroprotection-possibilities in perspective","volume":"45","author":"Weinreb","year":"2001","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.clintera.2004.12.007_bib115","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/ajhp\/58.12.1126","article-title":"Practical approach to determining costs and frequency of adverse drug events in a health care network","volume":"58","author":"Senst","year":"2001","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.clintera.2004.12.007_bib116","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0039-6257(01)00286-7","article-title":"Primary drug treatment for glaucoma: Beta-blockers versus other medications","volume":"47","author":"Stamper","year":"2002","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.clintera.2004.12.007_bib117","series-title":"Timoptic","year":"1995"},{"key":"10.1016\/j.clintera.2004.12.007_bib118","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/jama.245.14.1460","article-title":"Timolol-induced bronchospasm in asthmatic bronchitis","volume":"245","author":"Schoene","year":"1981","journal-title":"JAMA"},{"key":"10.1016\/j.clintera.2004.12.007_bib119","first-page":"80","article-title":"Acute episode of asthma following topical administration of betaxolol eyedrops","volume":"28","author":"Ananthanarayan","year":"1993","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.clintera.2004.12.007_bib120","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/eye.1993.151","article-title":"Improved lung function tests on changing from topical timolol: Non-selective beta-blockade impairs lung function tests in elderly patients","volume":"7","author":"Diggory","year":"1993","journal-title":"Eye"},{"key":"10.1016\/j.clintera.2004.12.007_bib121","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00055735-199704000-00008","article-title":"The role of alpha-agonists in glaucoma therapy","volume":"8","author":"Robin","year":"1997","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.clintera.2004.12.007_bib122","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1472-6904-1-3","article-title":"Reporting of adverse drug reactions in randomised controlled trials\u2014a systematic survey","volume":"1","author":"Loke","year":"2001","journal-title":"BMC Clin Pharmacol"},{"key":"10.1016\/j.clintera.2004.12.007_bib123","first-page":"598","article-title":"Relating spontaneous adverse experience reports to scores on a questionnaire querying tolerability","volume":"33","author":"Barber","year":"1995","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.clintera.2004.12.007_bib124","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1080\/080370599438266","article-title":"Adverse drug reactions in current antihypertensive therapy: A general practice survey of 2586 patients in Norway","volume":"8","author":"Olsen","year":"1999","journal-title":"Blood Press"},{"key":"10.1016\/j.clintera.2004.12.007_bib125","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.271.20.1615","article-title":"Users' Guides to the Medical Literature. IV. How to use an article about harm","volume":"271","author":"Levine","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.clintera.2004.12.007_bib126","first-page":"233","article-title":"Compliance in patients prescribed eyedrops for glaucoma","volume":"26","author":"Patel","year":"1995","journal-title":"Ophthalmic Surg"},{"key":"10.1016\/j.clintera.2004.12.007_bib127","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00061198-200310000-00001","article-title":"Compliance barriers in glaucoma: A systematic classification","volume":"12","author":"Tsai","year":"2003","journal-title":"J Glaucoma"},{"key":"10.1016\/j.clintera.2004.12.007_bib128","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0002-9394(14)74225-4","article-title":"Compliance with topical timolol treatment","volume":"103","author":"Kass","year":"1987","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clintera.2004.12.007_bib129","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0002-9394(86)90939-6","article-title":"Compliance with topical pilocarpine treatment","volume":"101","author":"Kass","year":"1986","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clintera.2004.12.007_bib130","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/eye.1998.56","article-title":"Compliance with timolol treatment in glaucoma","volume":"12","author":"Rotchford","year":"1998","journal-title":"Eye"},{"key":"10.1016\/j.clintera.2004.12.007_bib131","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00061198-199201020-00012","article-title":"Therapeutics and techniques. Compliance with medical treatment of glaucoma","volume":"1","author":"Weinreb","year":"1992","journal-title":"J Glaucoma"},{"key":"10.1016\/j.clintera.2004.12.007_bib132","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0149-2918(01)80109-0","article-title":"A systematic review of the associations between dose regimens and medication compliance","volume":"23","author":"Claxton","year":"2001","journal-title":"Clin Ther"},{"key":"10.1016\/j.clintera.2004.12.007_bib133","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00061198-199910000-00008","article-title":"The dorzolamide\/timolol combination versus timolol plus pilocarpine: Patient preference and impact on daily life","volume":"8","author":"Sverrisson","year":"1999","journal-title":"J Glaucoma"},{"key":"10.1016\/j.clintera.2004.12.007_bib134","first-page":"28","article-title":"Improving drug concordance in patients with chronic conditions","volume":"100","author":"Shuttleworth","year":"2004","journal-title":"Nurs Times"},{"key":"10.1016\/j.clintera.2004.12.007_bib135","first-page":"152","article-title":"Addressing the needs of patients with multiple chronic illnesses: The case of diabetes and depression","volume":"10","author":"Piette","year":"2004","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.clintera.2004.12.007_bib136","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0002-9394(14)71282-6","article-title":"Factors associated with visual loss in patients with advanced glaucomatous changes in the optic nerve head","volume":"116","author":"Stewart","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clintera.2004.12.007_bib137","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1017\/S0266462399015299","article-title":"Modeling cost of treatment with new topical treatments for glaucoma. Results from France and the United Kingdom","volume":"15","author":"Kobelt","year":"1999","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.clintera.2004.12.007_bib138","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0002-9394(99)00235-4","article-title":"Cost considerations of medical therapy for glaucoma","volume":"128","author":"Fiscella","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clintera.2004.12.007_bib139","series-title":"Primary Open-Angle Glaucoma: Differences in International Treatment Patterns and Costs","article-title":"What triggers change of therapy?","author":"Rouland","year":"1999"},{"key":"10.1016\/j.clintera.2004.12.007_bib140","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1136\/bjo.86.5.551","article-title":"The effects of new topical treatments on management of glaucoma in Scotland: An examination of ophthalmological health care","volume":"86","author":"Bateman","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clintera.2004.12.007_bib141","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/00061198-200406000-00008","article-title":"Trends in glaucoma surgery before and after the introduction of new topical glaucoma pharmacotherapies","volume":"13","author":"Strutton","year":"2004","journal-title":"J Glaucoma"},{"issue":"Suppl 4","key":"10.1016\/j.clintera.2004.12.007_bib142","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1177\/112067210301304S06","article-title":"Changes in medical and surgical treatments of glaucoma between 1997 and 2000 in France","volume":"13","author":"Baudouin","year":"2003","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.clintera.2004.12.007_bib143","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1001\/archopht.1994.01090150059023","article-title":"Functional status and quality of life measurement among ophthalmic patients","volume":"112","author":"Scott","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clintera.2004.12.007_bib144","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0161-6420(98)93043-3","article-title":"Glaucoma's impact on quality of life and its relation to clinical indicators. A pilot study","volume":"105","author":"Sherwood","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clintera.2004.12.007_bib145","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0161-6420(00)00624-2","article-title":"Quality of life in newly diagnosed glaucoma patients: The Collaborative Initial Glaucoma Treatment Study","volume":"108","author":"Janz","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clintera.2004.12.007_bib146","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/S0161-6420(01)00874-0","article-title":"The Collaborative Initial Glaucoma Treatment Study: Interim quality of life findings after initial medical or surgical treatment of glaucoma","volume":"108","author":"Janz","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clintera.2004.12.007_bib147","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/sj.eye.6700036","article-title":"Quality of life in patients with early, moderate and advanced glaucoma","volume":"16","author":"Iester","year":"2002","journal-title":"Eye"},{"key":"10.1016\/j.clintera.2004.12.007_bib148","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1600-0420.1998.tb00887.x","article-title":"Glaucoma and quality of life","volume":"227","author":"Perfetti","year":"1998","journal-title":"Acta Ophthalmol Scand Suppl"},{"key":"10.1016\/j.clintera.2004.12.007_bib149","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00055735-199904000-00005","article-title":"The role of medical therapy in the rank order of glaucoma treatment","volume":"10","author":"Wilensky","year":"1999","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.clintera.2004.12.007_bib150","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1542\/peds.108.2.432","article-title":"Comparison of quality of care by specialist and generalist physicians as usual source of asthma care for children","volume":"108","author":"Diette","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.clintera.2004.12.007_bib151","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1001\/archinte.158.15.1596","article-title":"Comparing generalist and specialty care: Discrepancies, deficiencies, and excesses","volume":"158","author":"Donohoe","year":"1998","journal-title":"Arch Intern Med"},{"issue":"Suppl 3","key":"10.1016\/j.clintera.2004.12.007_bib152","first-page":"S42","article-title":"How will primary care physicians, specialists, and managed care treat epilepsy in the new millennium?","volume":"55","author":"Montouris","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.clintera.2004.12.007_bib153","first-page":"676","article-title":"Improving the quality of outpatient care for older patients with diabetes: Lessons from a comparison of rural and urban communities","volume":"50","author":"Rosenblatt","year":"2001","journal-title":"J Fam Pract"},{"key":"10.1016\/j.clintera.2004.12.007_bib154","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1377\/hlthaff.20.6.61","article-title":"Toyotas or hush puppies? Physician organizations and chronic care management","volume":"20","author":"Oswald","year":"2001","journal-title":"Health Aff (Millwood)"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291804000773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291804000773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T01:11:36Z","timestamp":1706058696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291804000773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":154,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0149291804000773"],"URL":"https:\/\/doi.org\/10.1016\/j.clintera.2004.12.007","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}